XLV vs. PBPH
XLV (State Street Health Care Select Sector SPDR ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - XLV tracks the Health Care Select Sector Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their correlation of 0.86 suggests significant overlap in exposure. XLV charges 0.08%/yr vs 0.13%/yr for PBPH.
Performance
XLV vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLV achieves a -4.29% return, which is significantly lower than PBPH's -1.13% return.
XLV
- 1D
- 0.79%
- 1M
- 1.95%
- YTD
- -4.29%
- 6M
- -4.06%
- 1Y
- 12.89%
- 3Y*
- 5.98%
- 5Y*
- 5.55%
- 10Y*
- 9.20%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLV vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | -4.29% | -2.09% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between XLV and PBPH is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.86 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLV vs. PBPH — Risk / Return Rank
XLV
PBPH
XLV vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XLV | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.16 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | — | — |
| Martin ratioReturn relative to average drawdown | 2.99 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XLV | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.88 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | -0.04 | +0.50 |
Drawdowns
XLV vs. PBPH - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.17%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for XLV and PBPH.
Loading charts...
Drawdown Indicators
| XLV | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.17% | -11.10% | -28.07% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -17.11% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -17.11% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | — | — |
Current DrawdownCurrent decline from peak | -7.52% | -8.69% | +1.17% |
Average DrawdownAverage peak-to-trough decline | -7.12% | -4.23% | -2.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.32% | — | — |
Volatility
XLV vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| XLV | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.10% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.24% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 14.67% | 16.78% | -2.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.69% | 16.78% | -2.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.55% | 16.78% | -0.23% |
XLV vs. PBPH - Expense Ratio Comparison
XLV has a 0.08% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
XLV vs. PBPH - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.70%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV State Street Health Care Select Sector SPDR ETF | 1.70% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
XLV and PBPH have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLV is cheaper at 0.08% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLV is cheaper with a 0.08% expense ratio, compared with 0.13% for PBPH.
XLV has the higher dividend yield at 1.70%, compared with 0.09% for PBPH.
XLV tracks Health Care Select Sector Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: State Street and Portfolio Building Block. Their fees differ too: 0.08% for XLV and 0.13% for PBPH.
Find the right allocation for XLV and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer